Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | TSHR | P16473 | 5/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23618019 | 0.87 | TSHR (0.41) | ALDH1A1TSHRCYP3A4 | |
| SCHEMBL3971997 | 0.81 | ALDH1A1 (0.61) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL25159188 | 0.80 | ALDH1A1 (0.45) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL79568 | 0.79 | TSHR (0.65) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL28138798 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL8762270 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL28284146 | 0.76 | ALDH1A1 (0.55) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL7100185 | 0.76 | TSHR (0.67) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL28228553 | 0.76 | TSHR (0.55) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 | |
| SCHEMBL16335203 | 0.76 | TSHR (0.67) | ALDH1A1TSHRCYP3A4TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023107696-A2 | INHIBITORS OF MENIN-MLL INTERACTION | BALA THERAPEUTICS, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-10355221-B2 | Heterocyclic compound and organic solar cell comprising the same | LG CHEM, LTD. (KR) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10355221-B2 | Heterocyclic compound and organic solar cell comprising the same | SUN2, CRY1, STOM | ALDH1A1 1187/4885TSHR 4603/4885CYP3A4 708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.